CGEM vs TSLA · $830.3M cap vs P/E 179, rev $94.83B
Cullinan Oncology LLC (CGEM) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
CGEM currently screens at market cap $830.3M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the CGEM and TSLA stock pages for the full models.
Not investment advice.